The influence of metabolic syndrome in the outcomes of colorectal cancer patients

Detalhes bibliográficos
Autor(a) principal: Goulart, André
Data de Publicação: 2017
Outros Autores: Varejão, Ana, Nogueira, Fernanda, Martins, Sandra, Mesquita-Rodrigues, António, Sousa, Nuno, Leão, Pedro
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/1822/49012
Resumo: Aims: Determine the influence of metabolic syndrome and its different components in the outcomes of colorectal cancer surgery at 30 days. Materials and methods: Prospective study that included all patients submitted to elective colorectal cancer surgery between August 2015 and August 2016 at Hospital de Braga. Clinical and laboratory parameters evaluated pre-operatively were: central obesity, blood pressure, fasting glucose, triglycerides levels and HDL cholesterol levels. Any complications during the first 30-days after surgery were recorded (readmission, reintervention, anastomotic dehiscence, morbimortality). Results: One hundred and thirty-four patients were included. Metabolic syndrome was diagnostic in 40.7% of patients with the ATPIII definition, 67.5% with the AHA definition and 67.0% with the IDF definition. At 30 days after colorectal cancer surgery, 73.1% patients don't have any complication, 15.7% have minor complications (grade I/II of Clavien-Dindo classification), 11.1% have major complications (grade III/IV/V of Clavien-Dindo classification) and 1.5% have died from surgical complications (grade V of Clavien-Dindo classification). The statistic analysis didn't reveal any association between MS, or it's different components, and surgical outcomes. Conclusion: This study seems to indicate that metabolic syndrome don't have any influence in surgical outcomes of colorectal cancer surgery. (C) 2017 Diabetes India. Published by Elsevier Ltd. All rights reserved.
id RCAP_04869e0183f34b10dc179e2351db17e9
oai_identifier_str oai:repositorium.sdum.uminho.pt:1822/49012
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling The influence of metabolic syndrome in the outcomes of colorectal cancer patientsMetabolic syndromeColorectal cancerCiências Médicas::Medicina BásicaScience & TechnologyAims: Determine the influence of metabolic syndrome and its different components in the outcomes of colorectal cancer surgery at 30 days. Materials and methods: Prospective study that included all patients submitted to elective colorectal cancer surgery between August 2015 and August 2016 at Hospital de Braga. Clinical and laboratory parameters evaluated pre-operatively were: central obesity, blood pressure, fasting glucose, triglycerides levels and HDL cholesterol levels. Any complications during the first 30-days after surgery were recorded (readmission, reintervention, anastomotic dehiscence, morbimortality). Results: One hundred and thirty-four patients were included. Metabolic syndrome was diagnostic in 40.7% of patients with the ATPIII definition, 67.5% with the AHA definition and 67.0% with the IDF definition. At 30 days after colorectal cancer surgery, 73.1% patients don't have any complication, 15.7% have minor complications (grade I/II of Clavien-Dindo classification), 11.1% have major complications (grade III/IV/V of Clavien-Dindo classification) and 1.5% have died from surgical complications (grade V of Clavien-Dindo classification). The statistic analysis didn't reveal any association between MS, or it's different components, and surgical outcomes. Conclusion: This study seems to indicate that metabolic syndrome don't have any influence in surgical outcomes of colorectal cancer surgery. (C) 2017 Diabetes India. Published by Elsevier Ltd. All rights reserved.info:eu-repo/semantics/publishedVersionElsevierUniversidade do MinhoGoulart, AndréVarejão, AnaNogueira, FernandaMartins, SandraMesquita-Rodrigues, AntónioSousa, NunoLeão, Pedro2017-12-072017-12-07T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/1822/49012engGoulart, A., Varejão, A., Nogueira, F., Martins, S., Mesquita-Rodrigues, A., Sousa, N., & Leão, P. (2017). The influence of metabolic syndrome in the outcomes of colorectal cancer patients. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 11, S867-S871.1871-402110.1016/j.dsx.2017.07.00728711516https://www.sciencedirect.com/science/article/pii/S1871402117301765info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-21T12:12:36Zoai:repositorium.sdum.uminho.pt:1822/49012Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T19:04:32.893478Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv The influence of metabolic syndrome in the outcomes of colorectal cancer patients
title The influence of metabolic syndrome in the outcomes of colorectal cancer patients
spellingShingle The influence of metabolic syndrome in the outcomes of colorectal cancer patients
Goulart, André
Metabolic syndrome
Colorectal cancer
Ciências Médicas::Medicina Básica
Science & Technology
title_short The influence of metabolic syndrome in the outcomes of colorectal cancer patients
title_full The influence of metabolic syndrome in the outcomes of colorectal cancer patients
title_fullStr The influence of metabolic syndrome in the outcomes of colorectal cancer patients
title_full_unstemmed The influence of metabolic syndrome in the outcomes of colorectal cancer patients
title_sort The influence of metabolic syndrome in the outcomes of colorectal cancer patients
author Goulart, André
author_facet Goulart, André
Varejão, Ana
Nogueira, Fernanda
Martins, Sandra
Mesquita-Rodrigues, António
Sousa, Nuno
Leão, Pedro
author_role author
author2 Varejão, Ana
Nogueira, Fernanda
Martins, Sandra
Mesquita-Rodrigues, António
Sousa, Nuno
Leão, Pedro
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade do Minho
dc.contributor.author.fl_str_mv Goulart, André
Varejão, Ana
Nogueira, Fernanda
Martins, Sandra
Mesquita-Rodrigues, António
Sousa, Nuno
Leão, Pedro
dc.subject.por.fl_str_mv Metabolic syndrome
Colorectal cancer
Ciências Médicas::Medicina Básica
Science & Technology
topic Metabolic syndrome
Colorectal cancer
Ciências Médicas::Medicina Básica
Science & Technology
description Aims: Determine the influence of metabolic syndrome and its different components in the outcomes of colorectal cancer surgery at 30 days. Materials and methods: Prospective study that included all patients submitted to elective colorectal cancer surgery between August 2015 and August 2016 at Hospital de Braga. Clinical and laboratory parameters evaluated pre-operatively were: central obesity, blood pressure, fasting glucose, triglycerides levels and HDL cholesterol levels. Any complications during the first 30-days after surgery were recorded (readmission, reintervention, anastomotic dehiscence, morbimortality). Results: One hundred and thirty-four patients were included. Metabolic syndrome was diagnostic in 40.7% of patients with the ATPIII definition, 67.5% with the AHA definition and 67.0% with the IDF definition. At 30 days after colorectal cancer surgery, 73.1% patients don't have any complication, 15.7% have minor complications (grade I/II of Clavien-Dindo classification), 11.1% have major complications (grade III/IV/V of Clavien-Dindo classification) and 1.5% have died from surgical complications (grade V of Clavien-Dindo classification). The statistic analysis didn't reveal any association between MS, or it's different components, and surgical outcomes. Conclusion: This study seems to indicate that metabolic syndrome don't have any influence in surgical outcomes of colorectal cancer surgery. (C) 2017 Diabetes India. Published by Elsevier Ltd. All rights reserved.
publishDate 2017
dc.date.none.fl_str_mv 2017-12-07
2017-12-07T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/1822/49012
url http://hdl.handle.net/1822/49012
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Goulart, A., Varejão, A., Nogueira, F., Martins, S., Mesquita-Rodrigues, A., Sousa, N., & Leão, P. (2017). The influence of metabolic syndrome in the outcomes of colorectal cancer patients. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 11, S867-S871.
1871-4021
10.1016/j.dsx.2017.07.007
28711516
https://www.sciencedirect.com/science/article/pii/S1871402117301765
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799132454785646592